QuiaPEG Pharmaceuticals Holding AB (publ) (QUIA.ST)
SEK 0.02
(0.0%)
SEK 0.02
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.26 Million | -18.17 Million | -20.11 Million | -28.3 Million | -15.11 Million | -10.39 Million |
| Net Income | -16.52 Million | -15.79 Million | -17.56 Million | -24.93 Million | -18.05 Million | -11.5 Million |
| Depreciation & Amortization | 3.85 Million | 3.36 Million | 1.56 Million | 1.26 Million | 861 Thousand | 306 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.07 Million | -1.45 Million | -2.31 Million | -1.83 Million | 2.93 Million | 1.35 Million |
| Other non-cash items | 326 Thousand | -4.29 Million | -1.79 Million | -2.8 Million | -850 Thousand | -550 Thousand |
| Investing Cash Flow | -24.37 Million | -5.57 Million | -8.59 Million | -2.5 Million | -4.92 Million | -3.54 Million |
| Investments in PPE | -24.37 Million | -5.57 Million | -8.59 Million | -2.5 Million | -4.92 Million | -3.54 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -24.37 Million | -5.57 Million | -8.51 Million | 1000.00 | 1000.00 | -3.37 Million |
| Financing Cash Flow | 32.17 Million | 20.97 Million | 25.45 Million | 34.85 Million | 21.69 Million | 10.95 Million |
| Debt repayment | -18.5 Million | -1.5 Million | -11.14 Million | -11.27 Million | -767 Thousand | -463 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 13.67 Million | 22.47 Million | 19.95 Million | 33.18 Million | 10.46 Million | 10.41 Million |
| Other Financing Activities | -1.00 | -1.5 Million | 16.65 Million | 12.95 Million | 12 Million | 1 Million |
| Accounts receivables | -467 Thousand | -247 Thousand | -76 Thousand | -53 Thousand | -157 Thousand | 280 Thousand |
| Accounts payables | 2.53 Million | -1.21 Million | -2.23 Million | -1.78 Million | 3.08 Million | 1.07 Million |
| Inventory | -2.53 Million | 1.21 Million | 2.23 Million | 1.78 Million | -3.08 Million | - |
| Other working capital | 2.53 Million | -1.21 Million | -2.23 Million | -1.78 Million | 3.08 Million | 1.07 Million |
| Cash at beginning of period | 2.56 Million | 5.34 Million | 8.58 Million | 4.54 Million | 2.88 Million | 5.86 Million |
| Cash at end of period | 101 Thousand | 2.56 Million | 5.34 Million | 8.58 Million | 4.54 Million | 2.88 Million |
| Capital Expenditure | -24.37 Million | -5.57 Million | -8.59 Million | -2.5 Million | -4.92 Million | -3.54 Million |
| Effect of forex changes on cash | 1.00 | - | 1000.00 | -1000.00 | -1000.00 | - |
| Net cash flow / Change in cash | -2.46 Million | -2.77 Million | -3.24 Million | 4.04 Million | 1.66 Million | -2.98 Million |
| Free Cash Flow | -34.64 Million | -23.75 Million | -28.7 Million | -30.81 Million | -20.03 Million | -13.93 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.58 Million | -3.58 Million | -16.52 Million | -3.34 Million | -3.34 Million | -4.91 Million |
| Depreciation & Amortization | 972.5 Thousand | 972.5 Thousand | 3.85 Million | 979 Thousand | 90 Thousand | 950.5 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 553 Thousand | 553 Thousand | 2.07 Million | 1 Million | 1 Million | 27 Thousand |
| Other non-cash items | - | - | 326 Thousand | -10.99 Thousand | 878 Thousand | 174 Thousand |
| Investing Cash Flow | - | - | -24.37 Million | -11.31 Million | -11.31 Million | -870.5 Thousand |
| Investments in PPE | - | - | -24.37 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -24.37 Million | -11.31 Million | -11.31 Million | -870.5 Thousand |
| Financing Cash Flow | 3.3 Million | 3.3 Million | 32.17 Million | 11.03 Million | 11.03 Million | 5.04 Million |
| Debt repayment | - | - | -18.5 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 13.67 Million | - | - | - |
| Other Financing Activities | 3.3 Million | 3.3 Million | -1.00 | 11.03 Million | 11.03 Million | 5.04 Million |
| Accounts receivables | -37.5 Thousand | -37.5 Thousand | -467 Thousand | -10 Thousand | -10 Thousand | -223.5 Thousand |
| Accounts payables | - | - | 2.53 Million | - | - | - |
| Inventory | - | - | -2.53 Million | - | - | - |
| Other working capital | 590.5 Thousand | 590.5 Thousand | 2.53 Million | 1.01 Million | 1.01 Million | 250.5 Thousand |
| Cash at beginning of period | - | - | 2.56 Million | - | - | - |
| Cash at end of period | 1.23 Million | 1.23 Million | 101 Thousand | -1.64 Million | -1.64 Million | 411 Thousand |
| Capital Expenditure | - | - | -24.37 Million | - | - | - |
| Effect of forex changes on cash | - | - | 1.00 | - | - | - |
| Net cash flow / Change in cash | 1.23 Million | 1.23 Million | -2.46 Million | -1.64 Million | -1.64 Million | 411 Thousand |
| Free Cash Flow | -2.06 Million | -2.06 Million | -34.64 Million | -1.36 Million | -1.36 Million | -3.76 Million |
9818
600120
RTNXF
WPLCF
QSR
SMHN